EUMEDICA PHARMACEUTICAL seeks to ensure the development and continuity of vital treatment in serious indications.
Negaban temocillin, a 6-??methoxy penicillin derivative (?-lactam), has a sustained profile of susceptibility, more than a decade after its introduction into daily clinical practice. Negaban temocillin has a narrow spectrum directed towards gram-negative bacteria with a proven stability against all types of ß-lactamases, including ESBLs and AmpCs.